Luciole Medical

1. Executive Summary (Confidence: High)

Luciole Medical has established a first-mover position in the brain monitoring market with a platform that measures critical brain function parameters across a broad range of hospital settings. Headquartered in Zurich, the company is unique in having obtained market approval (CE-mark) for both its non-invasive adhesive patch and its intracranial probe. In June 2023, Luciole significantly expanded its market presence and manufacturing capacity by acquiring Spiegelberg GmbH & Co. KG, a specialized German provider of neurosurgical equipment. With a leadership team of seasoned MedTech executives, Luciole is transforming brain monitoring by establishing cerebral blood flow (CBF) and oxygenation as "vital signs" for better patient care.